Liquidia Corporation Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for LQDA, updated each market day.
LQDA AI Sentiment
AI sees no strong directional signal for Liquidia Corporation Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Liquidia Corporation Common Stock
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Sector
Exchange
Market Cap
$3,552,773,777
Cap Tier
Employees
216
Headquarters
MORRISVILLE, NC
Listed Since
July 26, 2018
Website
LQDA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LQDA Volatility
Liquidia Corporation Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
